Showing results (2021-2030 of 3,871) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|May 5, 2016
Hawaii natural compounds are promising to reduce ovarian cancer deathsDavid J Fei-Zhang, Chunshun Li, Shugeng CaoCancer Biology & Therapy|October 21, 2017
Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell featuresH Was, J Czarnecka, A Kominek, et al.Cancer Biology & Therapy|October 21, 2017
Overexpression of HN1L promotes cell malignant proliferation in non-small cell lung cancerLei Li, Ting-Ting Zeng, Bao-Zhu Zhang, et al.Cancer Biology & Therapy|May 2, 2022
GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinomaHaoji Gao, Weige Wang, Qinyu LiCancer Biology & Therapy|September 26, 2019
Diminished S-adenosylmethionine biosynthesis and its metabolism in a model of hepatocellular carcinoma is recuperated by an adenosine derivativeMaría Guadalupe Lozano-Rosas, Enrique Chávez, Gabriela Velasco-Loyden, et al.Cancer Biology & Therapy|April 1, 2017
Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: A case report and literatures reviewXuquan Jing, Feng Li, Xue Meng, et al.Cancer Biology & Therapy|March 15, 2019
Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant settingZiping Wu, Lei Zhang, Jing Peng, et al.Cancer Biology & Therapy|February 22, 2019
Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinomaLi-Jun Xue, Xiao-Bei Mao, Xiao-Bei Liu, et al.Cancer Biology & Therapy|November 22, 2018
Successful treatment of a BRAF V600E-mutant extracranial metastatic anaplastic oligoastrocytoma with vemurafenib and everolimusLiangliang Shi, Zhenwei Zou, Qian Ding, et al.Cancer Biology & Therapy|March 9, 2019
Inhibition of Cdc42-intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growthByron J Aguilar, Yaxue Zhao, Huchen Zhou, et al.Pageof 388